← Open Payments lookup

GUSTAVO ALVA: Open Payments

NPI 1417030222 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,138,182 in 1,015 payments from 30 companies in 2025. Trend: 2023 $1,066,079 · 2024 $1,052,848 · 2025 $1,138,182

Speaker / faculty: $676,676Travel & lodging: $161,079Honoraria: $139,594Consulting: $129,973Food & beverage: $25,630Speaker / faculty: $5,225
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.144$178,998
E.R. Squibb & Sons, L.L.C.127$173,475
Axsome Therapeutics, Inc.112$160,403
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)133$134,051
Vanda Pharmaceuticals Inc.101$125,595
Otsuka America Pharmaceutical, Inc.55$69,012
Janssen Pharmaceuticals, Inc54$60,168
ABBVIE INC.75$56,123
Neurocrine BioSciences, Inc.61$48,004
Alkermes, Inc.45$46,513

Products named: Auvelity, COBENFY, CAPLYTA, FANAPT, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, VRAYLAR.

Industry payments across CA — which companies pay providers there.